BridgeMD
New treatment option for Cerebral Palsy
Official title Intensive Bimanual Intervention in Cerebral Palsy Children
ClinicalTrials.gov ID: NCT05423171
What this study is testing
- What it's testing
- Motor disorders related to cerebral palsy are often accompanied by sensory, cognitive, perceptive, communication and behavioural impairments. It has already been shown that intensive bimanual intervention can improve arm movement, but its impact on the spontaneous use of the most affected arm in everyday life remains to be established.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 17
You may be able to join if
- Having a diagnosis of cerebral palsy or spastic hemiparesis encephalopathy
- Having sensorimotor deficits of one or both upper limb (spastic hemiparesis with a dominance on one side of the body; Manual Ability Classification...
- Having cognitive capacities to understand and perform task of the study.
You likely can't join if
- Presenting other significant health problem which may interfere with the requested task or with the clinical intervention;
- Having Botox injection in one or both upper limbs with the 4 months prior to the intervention;
- Presenting significant uncorrected visual deficits. N.B. Having a ferromagnetic implant is not an exclusion criterion, such participant will be...
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.